As of 2025-08-11, the Relative Valuation of Novavax Inc (NVAX) is 71.70 USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.37 USD, the upside of Novavax Inc based on Relative Valuation is 756.6%.
The range of the Relative Valuation is 62.42 - 81.69 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 22.0x | 19.5x |
| Forward P/E multiples | 16.8x - 21.4x | 19.0x |
| Fair Price | 62.42 - 81.69 | 71.70 |
| Upside | 645.8% - 876.0% | 756.6% |
| Date | P/E |
| 2025-08-08 | 2.25 |
| 2025-08-07 | 2.36 |
| 2025-08-06 | 2.04 |
| 2025-08-05 | 1.81 |
| 2025-08-04 | 1.81 |
| 2025-08-01 | 1.76 |
| 2025-07-31 | 1.79 |
| 2025-07-30 | 1.84 |
| 2025-07-29 | 1.88 |
| 2025-07-28 | 1.96 |
| 2025-07-25 | 2.01 |
| 2025-07-24 | 2.05 |
| 2025-07-23 | 2.11 |
| 2025-07-22 | 1.94 |
| 2025-07-21 | 1.93 |
| 2025-07-18 | 1.88 |
| 2025-07-17 | 1.88 |
| 2025-07-16 | 1.87 |
| 2025-07-15 | 1.85 |
| 2025-07-14 | 1.87 |
| 2025-07-11 | 1.84 |
| 2025-07-10 | 1.91 |
| 2025-07-09 | 1.89 |
| 2025-07-08 | 1.89 |
| 2025-07-07 | 1.78 |
| 2025-07-03 | 1.83 |
| 2025-07-02 | 1.82 |
| 2025-07-01 | 1.78 |
| 2025-06-30 | 1.69 |
| 2025-06-27 | 1.71 |
| 2025-06-26 | 1.75 |
| 2025-06-25 | 1.74 |
| 2025-06-24 | 1.74 |
| 2025-06-23 | 1.70 |
| 2025-06-20 | 1.72 |
| 2025-06-18 | 1.69 |
| 2025-06-17 | 1.74 |
| 2025-06-16 | 1.89 |
| 2025-06-13 | 1.87 |
| 2025-06-12 | 1.92 |
| 2025-06-11 | 1.91 |
| 2025-06-10 | 1.94 |
| 2025-06-09 | 1.99 |
| 2025-06-06 | 2.00 |
| 2025-06-05 | 1.88 |
| 2025-06-04 | 1.92 |
| 2025-06-03 | 1.95 |
| 2025-06-02 | 1.90 |
| 2025-05-30 | 1.97 |
| 2025-05-29 | 1.93 |